Zevra Therapeutics, Inc. ( ZVRA) - Key Metrics
ZVRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.62 | $0.22 | $0.10 | $0.10 |
| 2025Q3 | $0.47 | -$0.01 | $0.08 | $0.07 |
| 2025Q2 | $0.47 | $1.36 | -$0.07 | -$0.07 |
| 2025Q1 | $0.38 | -$0.06 | -$0.15 | -$0.15 |
ZVRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 10.18 |
| 2025Q3 | ? | -244.53 |
| 2025Q2 | ? | 1.62 |
| 2025Q1 | ? | -32.69 |
ZVRA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.12% | ? |
| 2025Q4 | 1.12% | ? |
| 2025Q3 | 0.78% | ? |
| 2025Q2 | -0.79% | ? |
| 2025Q1 | -2.05% | ? |
ZVRA
Price: $12.62
52 week price:
Earnings Per Share: 2.01 USD
P/E Ratio: 5.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 647.9 million